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Abstract 
Nanoparticles contrast medium to enhance performance of X-ray computed 
tomography (CT) imaging are desirable. Their clinical translation requires 
biodistribution and pharmacodynamics assessing in vivo. Herein, we for the first time 
reported that tantalum carbide nanoparticles (TCNPs) synthesized by a one-step laser 
ablation method are suitable probes for CT imaging. Measurements showed that 
Hounsfield units value of TCNPs was greater than that of Iohexol in the same 
concentration and in vivo X-ray CT imaging using TCNPs accounted for bright and 
high-resolution CT images with long circulation time. More importantly, we made the 
surprising discovery that TCNPs catalyze the color reaction of enzyme substrate 
incorporated with H2O2, similar to that of natural horseradish peroxidase. Based on this 
reaction, a simple one-step histochemical method was proposed for visualizing and 
quantifying the localization of TCNPs in the tissues or organs and further determining 
their biodistribution in mice. The novel approach avoids complex labeling and renders 
the possibility to learn the real state of TCNPs as contrast medium. These results 
proposed TCNPs are promising dual-functional agents for imaging and ex vivo 
localization.  
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Introduction 
Tantalum is a hard, ductile, and highly chemical-resistant metal with excellent 
bioperformance, developed as stents, sutures, and implants1. It is known to be 
inherently bioinert, demonstrating no remarkable inflammatory response under in vivo 
conditions. Depending on the required application, tantalum based materials can be 
usually available in bulk form and in coating form2. Recently, tantalum oxide 
nanoparticles have been proposed as promising agents for X-ray computed tomography 
(CT) imaging3. Present CT contrast medium approved for clinical use are iodine 
containing molecules4-5. They are efficient in absorbing X-rays, but rapidly cleaned by 
kidneys due to their small size, resulting in short circulation time. Moreover, it is 
necessary to use high concentration of iodine containing agents to provide adequate 
contrast, which may cause serious side-effects in patients6-9. As compared to 
conventional iodine containing molecules, tantalum oxide nanoparticles are featured by 
significant contrast increase and extended blood circulation time10.  
Clinical translation of nanoparticles in CT imaging requires extensive risk 
assessment for biodistribution and pharmacodynamics profiles after injection are 
crucial. Nevertheless, precise detection of nanoparticles ex/in vivo remains elusive. 
Factors such as surface properties, hydrodynamic size, and dispersibility are expected 
to influence interactions with biological systems11-13. Hence, biodistribution studies are 
often performed employing optical and radioisotopic tracers conjugated to 
nanoparticles as imaging agents14-15. However, the surface properties of nanoparticles 
and their distribution in body are probably being affected by exogenous labeling. 
Furthermore, the inevitable deposition of labels often causes false detection results in 
long-term monitoring16. Thus, developing new technology by using their intrinsic 
characteristics to ensure in situ detection of nanoparticles is desirable. In recent years, 
ex vivo detection of Fe3O4 nanoparticles in mice using their enzymatic activity was 
proposed, showing higher sensitivity than traditional Prussian blue assay17.  
Here we synthesized TCNPs by a one-step laser-induced method, i.e., laser 
ablation in liquid (LAL)18-19. Our experiments showed that Hounsfield units value of 
TCNPs was greater than that of clinical iodinated molecules in equivalent dose. 
Furthermore, in vivo X-ray CT imaging using TCNPs accounted for bright and high-
resolution CT images with long circulation time. More importantly, we made the 
surprising discovery that TCNPs possess peroxidase-mimicking activity, catalyzing the 
oxidation of natural enzyme substrate incorporated with H2O2 to generate a 
characteristic color reaction. Based on this reaction, a simple histochemical method was 
proposed for visualizing and quantifying the localization of TCNPs in the tissues or 
organs and further determining their biodistribution and pharmacodynamics in mice 
(Scheme 1). The novel approach avoids complex labeling and renders the possibility to 
determine the real state of TCNPs as contrast agent ex vivo by using their intrinsic 
properties. 
Results and discussion 
After laser ablation of Ta target in absolute ethanol for 5 min, color of the suspension 
changed from colorless to grey. The supernatant was collected for further 
characterization. TEM image in Figure 1a proposes that the products are mostly of 
spherical shape. A statistical analysis of 100 particles indicates that the diameter of 
TCNPs, ranging from 10-100 nm, have an average size of 40 nm. EDS spectrum 
demonstrates the main ingredient elements of Ta and C (Figure 1b). As shown in Figure 
1c, the corresponding XRD measurements propose the patterns of the laser ablated 
products are indexed to two forms of tantalum carbide including Ta4C3 with cubic 
structure (JCPDS card No. 65-0025) and Ta2C with trigonal structure (JCPDS card No. 
65-3191). HRTEM image in Figure 1d further supports the results of XRD patterns, 
demonstrating clear lattice fringes with planer spacing of 0.236 nm, 0.247 nm, and 
0.221 nm, in good agreement with (011) and (002) crystal plane of Ta2C, and (200) 
crystal plane of Ta4C3, respectively. The surface chemical states of Ta in TCNPs were 
analyzed by XPS spectrum. The high resolution spectrum of the Ta 4f peak could be 
decomposed into six main components (Figure 1e)20. Two high energy peaks at 25.90 
and 27.88 eV corresponding to 4f7/2 and 4f5/2 components of Ta
5+ and four low energy 
peaks at 23.61 and 22.89 eV assigned to the 4f7/2 peaks of Ta
3+ and Ta2+, respectively, 
and at 26.88 and 24.59 eV assigned to the 4f5/2 components of Ta
3+ and Ta2+, 
respectively. The Ta3+ and Ta2+ signals can be derived from Ta4C3 and Ta2C phases in 
TCNPs, respectively, and the oxidized (5+) state of Ta is probably deriving from the 
defects or oxides formed on the surface of TCNPs. ICP-AES test stressed that the 
TCNPs is about 74% by weight tantalum. The particle size distribution of the TCNPs 
solution was monitored by DLS measurements. The peak of the particle hydrodynamic 
diameters distribution locates at around 378 nm (Figure 1f). 
Biocompatibility assays are needed for application of TCNPs in vitro and in vivo. 
The in vitro experiment of the TCNPs was examined by CCK-8 assay21. GES-1 cells 
and HEp-2 cells viability was recorded at 12 h, 24 h, and 36 h after incubation with 
varied concentrations (1−20 µM Ta) of TCNPs, respectively. Control experiments were 
performed in parallel without TCNPs. As shown in Figure 1g and h, TCNPs did not 
significantly affect GES-1 cells viability up to 20 µM Ta. Further, in the case of HEp-2 
cells, there were not distinction between negative control group and TCNPs groups with 
time and concentration. Hence, these results propose that TCNPs have insignificant 
harmful effects on cells viability and differentiation, and the cytotoxicity of the TCNPs 
is relative satisfactory.  
Though the TCNPs with minimal cytotoxcity and good efficiency in vitro, it is 
essential for nano-based biomedicine to evaluate their immunotoxicity in vivo. In 
general, the expression of clusters of differentiation (CD) are very crucial for the 
immune response. For example, CD206 and CD11b are CD markers of innate immunity 
and CD25, CD69 and CD71 are are CD markers of adaptive immunity22-24. Their 
expression levels are an important parameter in evaluating the immune response25. The 
results of immunotoxicity on the TCNPs are shown in Figure 2. As we can see that, 
there are insignificant diffterences for expression levels of all the CD markers between 
TCNPs group and Gd-DTPA group at 7d after injection (P=0.05). It is demonstrated 
that the TCNPs do not stimulate the innate and adaptive cells after injection, and the 
immunotoxicity in vivo of TCNPs is also satisfactory. 
To assess the effect of CT contrasts, the X-ray absorption of TCNPs was compared 
to that of Iohexol in vitro. Figure 3a shows a high positive correlation between the 
Housfield units (HU) values and concentration for both TCNPs and Iohexol. At 
equivalent concentration, the HU value of TCNPs was greater than that of Iohexol since 
the attenuation coefficient of Ta (4.3 cm2 kg-1 at 100 KeV) was higher than that of I 
(1.94 cm2 kg-1 at 100 KeV)3, 10. The X-ray CT phantom images in Figure 3b show that 
TCNPs offered significantly higher contrast enhancement than Iohexol (Figure 3b). The 
important problem with the development of CT contrast agents is their relatively low 
sensitivity of the CT signal8. The TCNPs developed by us demonstrate an increased 
contrast at an equivalent dose in comparison with the clinical Iodinated molecules. 
Hence, TCNPs as contrast agents are able to show CT imaging signal with higher 
sensitivity. Further, lower dose requirement in this case may benifit a contrast agent 
because it decreases underlying side-effects in body in clinical applications7. In view 
of its low cytotoxicity and high CT efficacy, we then evaluated the feasibility of TCNPs 
as a CT contrast agent in vivo. TCNPs suspended in saline solution was intratumorally 
injected into a mouse. The CT imaging were performed before injection as well as 1h 
injection, and side-effects were examined in the tumor. Figure 3c shows that, after 
administration of TCNPs, clear contrast enhancement than other soft tissue could be 
observed at injection site, because of the TCNPs inducing a strong X-ray attenuation. 
Additionally, 3D-renderings of CT images were performed. The results also present 
distinct improvement of the tumor signals at the same time intervals (Figure 3d). 
To study the nanozyme activity of TCNPs, color reaction was performed in the 
absence and presence of H2O2, choosing TMB as the substrate26-28. With the 
involvement of H2O2, the TMB color evolution was much faster and exhibited deeper 
color in the same period of time (Figure 4a). However, the control experiments without 
TCNPs showed negligible color variation, proposing that all these components are 
necessary to stimulate the reaction. The UV-vis absorbance spectrum of the blue 
product showed absorbance peak at 652 nm, exhibiting the POD-like activity of TCNPs 
(Figure 4b)29-32. The origin of the POD-like activity should also be considered worthy 
of attention. The Ta 4f XPS spectrum in Figure 1e proposes the presence of Ta3+, Ta2+, 
and defects on the surface of TCNPs. We proposed that the Ta3+/Ta2+ redox couple can 
promote the electron transfer process between H2O2 and TMB in a Ta3+ ↔ Ta2+ 
switching manner, which is responsible for the peroxidase mimetic behavior29, 33. Also, 
the defects are also likely to take a role in concerning the origin of the POD-like 
activity34-35. Further experimental evidences are needed.  
By taking advantage of the POD-like activity of TCNPs that can produce a color 
precipitate, we first evaluated the cell permeability of the TCNPs. The TCNPs and TMB 
incubated HEp-2 cells show a distinct intracellular blue color deposition in the 
microscope image, indicating that the TCNPs can easily permeate into the cell (Figure 
4c). The DAB incubated cells show similar results, forming a brown color deposition 
at the site of TCNPs (Figure 4d). These results propose the feasibility of this location 
method and the possibility of detection the biodistribution of TCNPs ex vivo17. After 
intravenously administrated by TCNPs, the mice were sacrificed and their organs were 
collected and embedded in paraffin sections and stained with POD-like assay using 
TMB as substrate. The TCNPs can catalyze the oxidation of TMB in the presence of 
H2O2 and make a blue deposition at the sites of TCNPs (Figure 5). We can see that 
TCNPs were localized clearly in heart, lung, and liver. Rare intake of TCNPs was 
observed in the other organs. Hence, visualizing TCNPs in tissues by utilizing their 
peroxidase activity was realized, avoiding exogenous labeling. Further, the 
pharmacokinetics and organ clearance of CT contrast agents can be factually evaluated 
to understand their in vivo behavior.  
Conclusion 
In summary, we synthesized TCNPs by a one-step method of laser ablation in liquid. 
Our measurements indicated that TCNPs show higher HU value than that of clinical 
iodinated molecules at equivalent concentration. Furthermore, in vivo CT imaging 
using TCNPs resulted in bright and high-resolution CT images. More importantly, we 
found that TCNPs possess peroxidase-mimicking activity, catalyzing the oxidation of 
natural enzyme substrate in the presence of H2O2 to produce a characteristic color 
reaction. Based on this reaction, a histochemical method was proposed for visualizing 
and quantifying the localization of TCNPs in the main tissues or organs and further 
determining their biodistribution in mice. The novel approach avoids complex labeling 
and offers the possibility to learn the real state of TCNPs as contrast agent ex vivo by 
using their intrinsic enzyme mimetic properties. 
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Figure Captions 
Scheme 1. Schematic illustration of the preparation of TCNPs by LAL and their 
applications for CT imaging and unlabeled localization. 
 
Figure 1. Characterizations of TCNPs. (a) TEM image of TCNPs. The inset is the 
statistic analysis of diameter of TCNPs. (b) EDS spectrum of TCNPs. (c) XRD 
spectrum of TCNPs. (d) HRTEM image of TCNPs. (e) High-resolution Ta 4f XPS 
spectra of TCNPs. (f) Size distribution of the TCNPs obtained by DLS analysis. (g) 
Cytotoxicity of TCNPs on HEp-2 cells as function of the concentration. (h) Cytotoxicity 
of TCNPs on GES-1 and HEp-2 cells with varied incubation time.  
 
Figure 2. In vivo immunotoxicity of TCNPs. (a) Flow cytometry scatter plot of 
monocytes and lymphocytes group in peripheral blood after injection TCNPs in Balb/c 
mice. (1) PE-CD3, FITC-CD25, (2) PE-CD3, FITC-CD69, (3) PE-CD3, FITC-CD71, 
(4) APC-F4/80, PE-CD206, (5) APC-F4/80, PE-CD11b. (b) Mean fluorescence 
intensity (MFI) of different CD markers in the monocytes and lymphocytes of 
peripheral blood at 7d after the injection of TCNPs by the tail veins of BALB/c mice 
(100 mM Ta, mean ± SD, n = 5 in each group).  
 
Figure 3. In vitro and in vivo CT imaging. (a) HU values of TCNPs and Iohexol with 
different concentrations. The error bars represent the standard deviation of three 
measurements. (b) In vitro CT images of TCNPs and Iohexol with different 
concentrations. (c) Serial CT coronal views of in vivo imaging on a mouse following 
intratumoral injection of TCNPs. (d) The corresponding 3D renderings of in vivo CT 
images.  
 
Figure 4. (a and b) TCNPs show peroxidase-like activity. The TCNPs catalyze the 
oxidation of TMB, in the presence of H2O2. (1) TCNPs + TMB, (2) TMB + H2O2, (3) 
TCNPs + TMB + H2O2. TCNPs-peroxidase staining of HEp-2 cells using substrates of 
(c) TMB and (d) DAB, respectively. Arrows indicate some of the stained TCNPs. The 
insets show the high resolution images of HEp-2 cells.  
 
Figure 5. TCNPs-peroxidase staining of paraffin-embedded heart, liver, and lung from 
TCNPs-administered mice. Arrows indicate some of the stained TCNPs. 
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